Tyra Biosciences (TYRA) Competitors

Vericel (NASDAQ:VCEL) and Tyra Biosciences (NASDAQ:TYRA) are both medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, institutional ownership, analyst recommendations, media sentiment, community ranking, profitability, earnings, dividends and risk.

Is VCEL or TYRA more profitable?

Vericel has a net margin of 1.56% compared to Tyra Biosciences' net margin of 0.00%. Vericel's return on equity of 1.48% beat Tyra Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vericel	1.56%	1.48%	0.96%
Tyra Biosciences	N/A	-24.56%	-23.31%

Which has more risk and volatility, VCEL or TYRA?

Vericel has a beta of 1.31, indicating that its stock price is 31% more volatile than the S&P 500. Comparatively, Tyra Biosciences has a beta of 1.17, indicating that its stock price is 17% more volatile than the S&P 500.

Does the media prefer VCEL or TYRA?

In the previous week, Tyra Biosciences had 5 more articles in the media than Vericel. MarketBeat recorded 11 mentions for Tyra Biosciences and 6 mentions for Vericel. Vericel's average media sentiment score of 1.42 beat Tyra Biosciences' score of 1.38 indicating that Vericel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Vericel	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tyra Biosciences	6 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has preferable earnings & valuation, VCEL or TYRA?

Vericel has higher revenue and earnings than Tyra Biosciences. Tyra Biosciences is trading at a lower price-to-earnings ratio than Vericel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vericel	$238.54M	8.81	-$3.18M	$0.03	1,391.33
Tyra Biosciences	N/A	N/A	-$69.13M	-$1.63	-6.04

Does the MarketBeat Community prefer VCEL or TYRA?

Vericel received 318 more outperform votes than Tyra Biosciences when rated by MarketBeat users. However, 77.08% of users gave Tyra Biosciences an outperform vote while only 61.74% of users gave Vericel an outperform vote.

Company	Underperform	Outperform
Vericel	Outperform Votes 355 61.74%	Underperform Votes 220 38.26%
Tyra Biosciences	Outperform Votes 37 77.08%	Underperform Votes 11 22.92%

Do insiders and institutionals believe in VCEL or TYRA?

84.1% of Tyra Biosciences shares are held by institutional investors. 5.2% of Vericel shares are held by company insiders. Comparatively, 15.4% of Tyra Biosciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Do analysts prefer VCEL or TYRA?

Vericel currently has a consensus target price of $60.86, suggesting a potential upside of 45.80%. Tyra Biosciences has a consensus target price of $30.83, suggesting a potential upside of 213.19%. Given Tyra Biosciences' higher possible upside, analysts plainly believe Tyra Biosciences is more favorable than Vericel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vericel	0 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	3.00
Tyra Biosciences	0 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Vericel beats Tyra Biosciences on 11 of the 16 factors compared between the two stocks.